跳至主要内容
临床试验/NCT06534801
NCT06534801尚未招募不适用

Sequential Method Determination of Oxycodone for Thoracoscope Surgery Median Effective Dose of Acute Pain Treatment

Jianbo Wu0 个研究点目标入组 60 人开始时间: 2024年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
主要终点
The median effective dose

研究概览

简要总结

The goal of this clinical trial is to measure the median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy. This clinical trial was divided into two groups based on age, Group I (Age < 65 years old) and Group II (Age ≥65 years old). We used the sequential allocation designed by Dixon. The initial oxycodone dose was set to 0.1 mg/kg.A satisfactory or an unsatisfactory analgesic response of the previous patient determined, respectively, the relative 10% decrease or increase in the dose of oxycodone the next patient received in the same group. The patient before the first crossover point was included as the first case for ED50 estimation in each group.The study was conducted until 7 crossover points were collected

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The first unilateral thoracoscopic lobectomy was performed under general anesthesia
  • •age 18- 80 years old
  • •American Society of Anesthesiologists (ASA) physical status I-III
  • •Sign the informed consent of the patients

排除标准

  • •Moderate to severe obesity (i.e., BMI > 30kg/m2)
  • •Allergic or hypersensitive reaction to oxycodon
  • •A history of chronic pain
  • •Patients with significant heart, pulmonary, liver or renal disease

研究组 & 干预措施

Group I(Age < 65 years old)

Experimental

We will use the sequential allocation designed by Dixon. Oxycodone will be administered intravenously 30min before the end of surgery. The initial oxycodone dose will be set to 0.1 mg/kg. A satisfactory or an unsatisfactory analgesic response of the previous patient determined, respectively, the relative 10% decrease or increase in the dose of oxycodone the next patient received in the same group. The patient before the first crossover point will be included as the first case for ED50 estimation in each group. The study will conducted until 7 crossover points have be collected .

干预措施: Oxycodone will be administered intravenously in the group 1 (Drug)

Group II(Age ≥65 years old)

Experimental

We will use the sequential allocation designed by Dixon. Oxycodone will be administered intravenously 30min before the end of surgery. The initial oxycodone dose will be set to 0.1 mg/kg. A satisfactory or an unsatisfactory analgesic response of the previous patient determined, respectively, the relative 10% decrease or increase in the dose of oxycodone the next patient received in the same group. The patient before the first crossover point will be included as the first case for ED50 estimation in each group. The study will conducted until 7 crossover points have be collected .

干预措施: Oxycodone will be administered intravenously in the group 1 (Drug)

结局指标

主要结局

The median effective dose

时间窗: 3 minutes after remoal of the endotracheal tube, 30minutes after remoal of the endotracheal tube

The median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy

次要结局

未报告次要终点

研究者

发起方
Jianbo Wu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jianbo Wu

Chief Physician

Qianfoshan Hospital

相似试验

Sequential Method Determination of Oxycodone for... | 临床试验